138733-50-3

Basic information

• Product Name: 2-Bromo-N-(tert-butyl)benzenesulphonamide
• Synonyms: 2-Bromo-N-(tert-butyl)benzenesulphonamide;2-Bromo-N-tert-butylbenzenesulfonamide;N-t-Butyl 2-bromobenzenesulfonamide;2-BROMO-N-(1,1-DIMETHYLETHYL)BENZENESULFONAMIDE
• CAS NO: 138733-50-3
• Molecular Formula: C₁₀H₁₄BrNO₂S
• Molecular Weight: 292.2
• Product Categories: blocks;Bromides;Sulfonamides
• Mol File: 138733-50-3.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 364.5°Cat760mmHg
• Flash Point: 174.2°C
• Appearance: /
• Density: 1.419g/cm³
• Vapor Pressure: 1.68E-05mmHg at 25°C
• Refractive Index: 1.549
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 11.58±0.50(Predicted)
• CAS DataBase Reference: 2-Bromo-N-(tert-butyl)benzenesulphonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-N-(tert-butyl)benzenesulphonamide(138733-50-3)
• EPA Substance Registry System: 2-Bromo-N-(tert-butyl)benzenesulphonamide(138733-50-3)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 138733-50-3(Hazardous Substances Data)

Usage

General Description

2-Bromo-N-(tert-butyl)benzenesulphonamide is an organic compound that consists of a benzene ring with a bromine atom and a tert-butyl group attached to a sulphonamide functional group. It is commonly used as a reagent in various chemical reactions, such as nucleophilic substitution and as a starting material in the synthesis of pharmaceuticals and agrochemicals. The compound has a wide range of applications in the pharmaceutical and chemical industries, including as an intermediate in the production of drugs, pesticides, and other organic compounds. Additionally, it is known for its ability to act as a selective inhibitor of specific enzymes, making it valuable for research purposes in biochemistry and molecular biology. Overall, 2-Bromo-N-(tert-butyl)benzenesulphonamide is an important and versatile chemical compound with diverse applications in various fields.

InChI:InChI=1/C10H14BrNO2S/c1-10(2,3)12-15(13,14)9-7-5-4-6-8(9)11/h4-7,12H,1-3H3

Upstream product

• 2905-25-1 o-bromobenzenesulfonyl chloride 
• 75-64-9 tert-butylamine 
• 7154-66-7 2-bromobenzoic acid chloride 

Downstream Products

• 851902-28-8 4'-formylbiphenyl-2-sulfonic acid t-butylamide 
• 154122-65-3 2'-t-butylaminosulfonyl-4-aminomethyl-[1,1']-biphenyl 
• 476352-36-0 2'-sulfamoyl-biphenyl-4-carboxylic acid [2-(3-cyano-phenoxy)-ethyl]-methyl-amide 
• 476352-32-6 2'-sulfamoyl-biphenyl-4-carboxylic acid [2-(3-cyano-phenoxy)-ethyl]-amide 
• 476352-33-7 2'-sulfamoyl-biphenyl-4-carboxylic acid [2-(3-cyano-phenoxy)-1-methyl-ethyl]-amide 
• 476352-29-1 2'-tert-butylsulfamoyl-biphenyl-4-carboxylic acid [2-(3-cyano-phenoxy)-1-methyl-ethyl]-amide 
• 309930-31-2 2'-tert-butylsulfamoyl-biphenyl-4-carboxylic acid [2-(3-cyano-phenoxy)-ethyl]-amide 
• 476352-34-8 2'-sulfamoyl-biphenyl-4-carboxylic acid [2-(3-cyano-phenoxy)-1-phenyl-ethyl]-amide 
• 476352-40-6 [[2-(3-cyano-phenoxy)-ethyl]-(2'-sulfamoyl-biphenyl-4-carbonyl)-amino]-acetic acid methyl ester 
• 476352-41-7 [[2-(3-cyano-phenoxy)-ethyl]-(2'-sulfamoyl-biphenyl-4-carbonyl)-amino]-acetic acid 
• 476352-37-1 2'-sulfamoyl-biphenyl-4-carboxylic acid benzyl-[2-(3-cyano-phenoxy)-ethyl]-amide 

Relevant articles and documents

Structurally Diverse Synthesis of Five-, Six-, and Seven-Membered Benzosultams through Electrochemical Cyclization

We have developed a metal- and oxidant-free approach to structurally diverse synthesis of benzosultams from aryl sulfonamides through an electrochemical cyclization. Upon variation of the ortho substituent on aryl sulfonamides, five-, six-, and seven-memb

DUAL-ACTING PYRAZOLE ANTIHYPERTENSIVE AGENTS

In one aspect, the invention relates to compounds having the formula: wherein: Ar, Z, R3, R4 and R5 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have AT1 re

Dual-acting antihypertensive agents

The invention is directed to compounds of formula I: wherein Ar, r, R3, X, and R5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula I have AT1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and a process and intermediates for preparing such compounds.